Wordt geladen...
Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia
Acute myelogenous leukemia (AML) is a heterogeneous disease and often relapses after standard chemotherapy. Recently, the neddylation (NEDD8) and the mammalian target of rapamycin (mTOR) signaling pathways have emerged as promising pharmaceutical targets for AML therapy. However, the interaction of...
Bewaard in:
| Gepubliceerd in: | Transl Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Neoplasia Press
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348338/ https://ncbi.nlm.nih.gov/pubmed/30699367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.01.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|